Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
AstraZeneca
Genmab
Seagen Inc.
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
Mayo Clinic
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Ohio State University
Mayo Clinic
Hoffmann-La Roche
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Erasca, Inc.
Ipsen
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Washington University School of Medicine
University of Florida
Arvinas Inc.